None listed
Conditions
Interventions
None listed
Sponsors
Yeongnam University Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Adult males and females aged 19 and above 2) ASA 1-3 3) BMI 18.5~30.0 4) SpO2 = 90% in ambient air or with no more than 2L/min of O2 support 5) Patients who can comply with the procedures according to this clinical study protocol and who have voluntarily signed the consent form themselves ,
Exclusion criteria
Exclusion criteria: 1) Patients undergoing both Radial EBUS and ENB simultaneously 2) ASA 4 or higher 3) Mallampati score 4 4) BMI 30.0 5) Known sensitivity to benzodiazepines, flumazenil, opioids, naloxone, or a medical condition in which these agents 6) Bronchoscopy outside the bronchoscopy unit 7) CKD on dialysis 8) Patients with a current active acute infection or uncontrolled chronic inflammatory lung disease 9) Patients considered inappropriate for the study at the investigator's discretion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Procedural success during EBUS-TBNA (composite outcome) | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to start of procedure after administration of the first dose of study medication;Requirement for flumazenil dosage during the procedure;Time taken to achieve full alertness after the procedure;Total fentanyl dose;Complications related to the procedure | — |
Countries
Korea, Republic of
Contacts
Public ContactJune Hong Ahn
Yeongnam University Medical Center
Outcome results
None listed